✦ LIBER ✦

Peginterferon alfa-2A (40KD) (PEGASYS) plus ribavirin (RBV) and amantadine (AMA) vs induction therapy with interferon alfa-2A (roferon-A) plus RBV and AMA in IFN/RBV nonresponder patients with chronic hepatitis C (CHC)

✍ Scribed by S. Fargion; M. Borzio; A. Cargnel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

475 Sustained virological response (SVR)

✍ S. Fargion; M. Borzio; A. Maraschi; A. Cargnel 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Re-treatment of interferon (IFN) plus ri

✍ S. Brillanti; A. Mangia; L. Cimino; A. Civolani; F. Fatuzzo; L. Fenoglio; M. Lev 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 166 KB

PEG-IFN alfa-2a (40kd) (Pegasys) plus am

✍ G. Ideo; A. Attili; G. Ruggiero; A. Craxi; G. Di Perri; A. Mangia; A. Picciotto; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 154 KB

A randomised controlled trial on pegylat

✍ A. Mangia; G.L. Ricci; N. Minerva; M. Persico; V. Carretta; D. Bacca; M. Cela; M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Pegylated 40KDA IFN alfa-2a plus amantad

✍ Gaetano Ideo; Mario Angelico; A. Chirianni; Antonio Craxi; G. Di Perri; L. Minol 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 111 KB

503 Early prediction of sustained virolo

✍ P.J. Pockros; M. Diago; E. Gane; K.R. Reddy; D. Prati; M.L. Shiffman; P. Farci; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 65 KB